Skip to main content
Log in

Acute changes in nigral substance P content induced by drugs acting on dopamine, muscarine and GABA receptors

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Effects of acutely administered drugs acting on dopamine, muscarine or GABA receptors on the substance P content in rat substantia nigra were examined. Systemic injection of apomorphine caused a significant reduction in the nigral substance P content. This effect was found to be partially inhibited by atropine pretreatment. Haloperidol completely abolished the effect of apomorphine, while sulpiride did not. When administered alone, haloperidol, sulpiride or atropine had no effect on the nigral substance P content. Oxotremopine, the muscarine receptor agonist, reduced substance P content in the rostral half of the substantia nigra. Reduction in the nigral substance P content was also induced by treatment with the GABA receptor antagonist picrotoxin. On the other hand, diazepam increased the substance P content.

These results suggest that the striatonigral substance P neurons could be regulated by dopaminergic, cholinergic and GABAergic systems, and that the dopaminergic influence on the substance P neurons may be mediated, at least in part, by the cholinergic system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Besson MJ, Kemel ML, Gauchy C, Glowinski J (1982) Bilateral asymmetrical changes in the nigral release of [3H]GABA induced by unilateral application of acetylcholine in the cat caudate nucleus. Brain Res 241:241–248

    Google Scholar 

  • Davies J, Dray A (1976) Substance P in the substantia nigra. Brain Res 107:623–627

    Google Scholar 

  • Dray A (1979) The striatum and substantia nigra: a commentary on their relationships. Neuroscience 4:1407–1439

    Google Scholar 

  • Dray A, Straughan DW (1976) Synaptic mechanisms in the substantia nigra. J Pharm Pharmacol 28:400–405

    Google Scholar 

  • Duka T, Wüster M, Herz A (1979) Rapid changes in enkephalin levels in rat striatum and hypothalamus induced by diazepam. Naunyn-Schmiedeberg's Arch Pharmacol 309:1–5

    Google Scholar 

  • Eison AS, Eison MS, Iversen SD (1982) Behavioural effects of a novel substance P analogue following infusion into the ventral tegmental area and substantia nigra of rat brain. Brain Res 238:137–152

    Google Scholar 

  • Gale K, Guidotti A, Costa E (1977) Dopaminergic sensitive adenylate cyclase: location in substantia nigra. Science 195:503–505

    Google Scholar 

  • Govoni S, Yang H-YT, Bosio A, Pasinetti G, Costa E (1982) Possible interaction between cholecystokinin and dopamine. In: Costa E, Trabucchi M (eds) Regulatory peptides: from molecular biology to function. Raven Press, New York, pp 437–444

    Google Scholar 

  • Groves PM (1983) A theory of the functional organization of the neostraatum and the neostriatal control of voluntary movement. Brain Res Rev 5:109–132

    Google Scholar 

  • Hanson G, Alphs L, Pradhan S, Lovenberg W (1981a) Response of striatonigral substance P systems to a dopamine receptor agonist and antagonist. Neuropharmacology 20:541–548

    Google Scholar 

  • Hanson G, Alphs L, Wolf W, Levine R, Lovenberg W (1981b) Haloperidol-induced reduction of nigral substance P-like immunoreactivity: a probe for the interactions between dopamine and substance P neuronal systems. J Pharmacol Exp Ther 218:568–574

    Google Scholar 

  • Hong JS, Yang H-YT, Costa E (1978) Substance P content of substantia nigra after chronic treatment with antischizophrenic drugs. Neuropharmacology 17:83–85

    Google Scholar 

  • James TA, Starr MS (1979) Effects of substance P injected into the substantia nigra. Br J Pharmacol 65:423–429

    Google Scholar 

  • Janicki P, Łypco A, Szczudlik A, Libich J (1981) Substance P levels in the rat forebrain after apomorphine and haloperidol treatment. Pol J Pharmacol Pharm 33:499–502

    Google Scholar 

  • Jessell TM (1978) Substance P release from the rat substantia nigra. Brain Res 151:469–478

    Google Scholar 

  • Kato T, Okada M, Koshiya K (1983) Analysis of neuropeptides and their physiological roles with monoamines. In: Parvez S, Nagatsu T, Nagatsu I, Parvez H (eds) Methods in biogenic amine research. Elsevier Biomedical Press, Amsterdam (in press)

    Google Scholar 

  • Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 227:93–96

    Google Scholar 

  • Kelly SE, Iversen SD (1979) Substance P infusion into substantia nigra of the rat: behavioural analysis and involvement of striatal dopamine. Eur J Pharmacol 60:171–179

    Google Scholar 

  • Koshiya K, Kato T (1982) Time-dependent changes in the immunoreactive substance P content in rat substantia nigra after acute treatment with a neuroleptic drug. Biomed Res 3:244–246

    Google Scholar 

  • König JF, Klippel RA (1963) The rat brain: a stereotaxic atlas of the forebrain and lower parts of the brain stem. Williams and Wilkins, Baltimore

    Google Scholar 

  • Lakoski JM, Mohrland JS, Gebhart GF (1980) The effect of morphine on the content of serotonin, 5-hydroxyindole acetic acid and substance-P in the nuclei raphe magnus and reticularis gigantocellularis. Life Sci 27:2639–2644

    Google Scholar 

  • Lavielle S, Tassin J-P, Thierry A-M, Blanc G, Herve D, Barthelemy C, Glowinski J (1978) Blockade by benzodiazepines of the selective high increase in dopamine turnover induced by stress in mesocortical dopaminergic neurons of the rat. Brain Res 168:585–594

    Google Scholar 

  • Lisoprawski A, Blanc G, Glowinski J (1981) Activation by stress of the habenulo-interpeduncular substance P neurons in the rat. Neurosci Lett 25:47–51

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Michelot R, Leviel V, Giorguieff-Chesselet MF, Chéramy A, Glowinski J (1979) Effects of the unilateral nigral modulation of substance P transmission on the activity of the two nigro-striatal dopaminergic pathways. Life Sci 24:715–724

    Google Scholar 

  • Pradhan S, Hanson G, Lovenberg W (1981) Inverse relation of substance-P like immunoreactivity in dorsal raphe nucleus to serotonin levels in pons-medulla following administration of cocaine and 5-hydroxytryptophan. Biochem Pharmacol 30:1071–1076

    Google Scholar 

  • Pérez de la Mora M, Fuxe K (1977) Brain GABA, dopamine and acetylcholine interactions. 1. Studies with oxotremorine. Brain Res 135:107–122

    Google Scholar 

  • Pettibone DJ, Wurtman RJ (1980) D-Amphetamine reduces striatal substance P concentrations by presynaptic release of dopamine. Brain Res 186:409–419

    Google Scholar 

  • Prezewlocki R, Gramsch C, Höllt V, Millan MJ, Osborne H, Herz A (1980) The distribution and release of β-endorphin in relation to certain possible functions. In: Marson CA, Traczyk WZ (eds) Neuropeptides and neural transmission, Raven Press, New York, pp 245–256

    Google Scholar 

  • Spano PF, Trabucchi M, Di Chiara G (1977) Localization of nigral dopamine-sensitive adenylate cyclase on neurons originating from the corpus striatum. Science 196:1343–1345

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koshiya, K., Kato, T. Acute changes in nigral substance P content induced by drugs acting on dopamine, muscarine and GABA receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 324, 223–227 (1983). https://doi.org/10.1007/BF00503899

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00503899

Key words

Navigation